The overall purpose of this application is to continue our work elucidating the mechanisms and processes involved in the control of glucose metabolism in humans; in particular, we shall focus on factors dealing with glucose production by liver and kidney. Presently the role of the kidney in glucose homeostasis in humans is poorly understood and somewhat controversial. Recent studies indicate that release of glucose by the kidney normally accounts on average for 20% of overall glucose release and for about 40% of all gluconeogenesis in the postabsorptive state. Furthermore, there is evidence that it could become more important in situations where alterations in gluconeogenesis are involved and where hepatic glucose production is reduced. Therefore it is proposed to use a combination of isotopic (U-13C glucose) and organ (renal) balance techniques to evaluate the regulation of renal glucose release and its contribution to glucose homeostasis in a variety of conditions where alterations in renal glucose release might be important, e.g. counterregulation of hypoglycemia in diabetic patients with impaired glucagon responses, patients with renal insufficiency, postprandial glucose physiology and pathophysiology. An underlying theme of these studies will be evaluation of the recently proposed novel concept Hepatorenal Glucose Reciprocity. According to this concept, reciprocal changes in hepatic and renal glucose release occur under both physiologic (e.g. postprandial suppression of hepatic glucose release) and pathologic (e.g. renal/hepatic disease) conditions so as to prevent hypoglycemia and/or optimize homeostatic processes (e.g. postprandial hepatic glycogen repletion). There is evidence that the kidney participates in defense against hypoglycemia which is generally considered to be a major rate-limiting factor in the management of diabetes mellitus. Moreover, there is evidence that excessive renal glucose release contributes to hyperglycemia in diabetes mellitus. Further knowledge of the control of renal glucose release could therefore have therapeutic implications for this disorder and in people with liver and kidney disease. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK020411-24A2
Application #
6683121
Study Section
Metabolism Study Section (MET)
Program Officer
Arreaza-Rubin, Guillermo
Project Start
1986-12-01
Project End
2008-06-30
Budget Start
2003-08-15
Budget End
2004-06-30
Support Year
24
Fiscal Year
2003
Total Cost
$509,235
Indirect Cost
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
King, Kathleen B; Gerich, John E; Guzick, David S et al. (2009) Is a history of gestational diabetes related to risk factors for coronary heart disease? Res Nurs Health 32:298-306
Emerson, Peter; Van Haeften, Timon W; Pimenta, Walkyria et al. (2009) Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus. Metabolism 58:602-7
Woerle, Hans J; Albrecht, Max; Linke, Rainer et al. (2008) Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care 31:2325-31
Woerle, H-J; Albrecht, M; Linke, R et al. (2008) Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab 294:E103-9
Szoke, Ervin; Shrayyef, Muhammad Z; Messing, Susan et al. (2008) Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care 31:539-43
Schwarz, S L; Gerich, J E; Marcellari, A et al. (2008) Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naive elderly patients with type 2 diabetes. Diabetes Obes Metab 10:652-60
Woerle, Hans J; Neumann, Christoph; Zschau, Silvia et al. (2007) Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract 77:280-5
Meyer, Christian; Pimenta, Walkyria; Woerle, Hans J et al. (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909-14
Szoke, Ervin; Gosmanov, Niyaz R; Sinkin, Jeremy C et al. (2006) Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism 55:78-83
Gerich, John E (2006) Postprandial hyperglycemia and cardiovascular disease. Endocr Pract 12 Suppl 1:47-51

Showing the most recent 10 out of 76 publications